Delivery Order SPE2DB22D3016-SPE2DB26FABQ1
- Not listed
- The Defense Logistics Agency awarded a $26,579.88 delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5 mL) on September 2, 2025, with completion scheduled for September 3, 2025. This competitively awarded, firm fixed-price contract represents a small component of the vendor's extensive pharmaceutical supply operations supporting federal medical procurement. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $4,196.78 delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Rotarix vaccine oral syringes (1.5ml). This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 4, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The vaccine will be delivered to the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Rotarix Vaccine Oral Syringe 1.5ML, with a ceiling value of $6,750.09. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion by August 5, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents no set-aside designation, indicating open competition among qualified vendors. This...
- The Defense Logistics Agency awarded a $2,953.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5 mL) on September 22, 2025, with an ultimate completion date of September 23, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,133.43 to supply Rotarix vaccine in oral syringe format (1.5ML) with a completion date of October 31, 2025. This is a firm fixed price delivery order issued on October 30, 2025, with no set-aside designation, indicating the award was made through competitive procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5mL) valued at $12,491.82 under a firm fixed price contract type. The award was made on September 22, 2025, with an ultimate completion date of September 23, 2025, and the performance location is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5mL) under a firm fixed-price contract valued at $11,462.30. The order, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a non-competitive, non-set-aside delivery of pharmaceutical products to support federal medical supply requirements. Performance will take place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $7,383.30 to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5ML) on June 25, 2025, with an ultimate completion date of June 26, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $6,959.21 to AmerisourceBergen Drug Corp for Rotarix vaccine in oral syringe format (1.5ml) on September 16, 2025, with completion scheduled for September 17, 2025. This competitively awarded, firm fixed-price delivery order was placed under no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $31,634 delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5mL) on September 29, 2025, with a completion date of September 30, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The contract will be performed at the contractor's corporate office...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB26FABQ1Delivery Order
The Defense Logistics Agency awarded a $23,445.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Rotarix vaccine oral syringes (1.5 mL) on November 6, 2025, with completion scheduled for November 7, 2025. The order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a small transaction within the broader federal pharmaceutical supply chain supporting military and veteran healthcare systems. This award is issued as a child order under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications, vaccines, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen Drug Corp's position as a major pharmaceutical distributor and established federal contractor demonstrates its capability to fulfill critical vaccine procurement needs for military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.4k | 11/6/25 |